The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...

Descripción completa

Detalles Bibliográficos
Autores principales: Legrand, Matthieu, Oufella, Hafid Ait, De Backer, Daniel, Duranteau, Jacques, Leone, Marc, Levy, Bruno, Rossignol, Patrick, Vicaut, Eric, Dépret, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://www.ncbi.nlm.nih.gov/pubmed/32611377
http://dx.doi.org/10.1186/s13063-020-04549-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://www.ncbi.nlm.nih.gov/pubmed/32611377
http://dx.doi.org/10.1186/s13063-020-04549-y

Ejemplares similares